Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
2.100
-0.220 (-9.48%)
At close: Mar 31, 2025, 4:00 PM
2.163
+0.063 (2.98%)
After-hours: Mar 31, 2025, 5:32 PM EDT
Curis Revenue
In the year 2024, Curis had annual revenue of $10.91M with 8.83% growth. Curis had revenue of $3.35M in the quarter ending December 31, 2024, with 24.07% growth.
Revenue (ttm)
$10.91M
Revenue Growth
+8.83%
P/S Ratio
1.21
Revenue / Employee
$222,612
Employees
49
Market Cap
17.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.91M | 885.00K | 8.83% |
Dec 31, 2023 | 10.02M | -139.00K | -1.37% |
Dec 31, 2022 | 10.16M | -487.00K | -4.57% |
Dec 31, 2021 | 10.65M | -186.00K | -1.72% |
Dec 31, 2020 | 10.84M | 831.00K | 8.31% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CRIS News
- 17 hours ago - Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 19 hours ago - Curis Provides Fourth Quarter 2024 Business Update - PRNewsWire
- 3 days ago - Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 - PRNewsWire
- 3 months ago - Curis Announces Additional Data from TakeAim Leukemia Study - PRNewsWire
- 4 months ago - Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Curis Provides Third Quarter 2024 Business Update - PRNewsWire
- 5 months ago - Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 - PRNewsWire
- 5 months ago - Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement - PRNewsWire